TNFRSF10D and neoplasm: In agreement, knockdown of anti-apoptotic TRAIL-R4 in some tumor cell lines did not enhance γδ T cell-mediated cytotoxicity, while strongly sensitized these cells to the treatment with recombinant TRAIL.